Foley Catheter vs Double-balloon Catheter

Sponsor
Kanuni Sultan Suleyman Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03521674
Collaborator
(none)
100
1
2
17.4
5.7

Study Details

Study Description

Brief Summary

The efficiency of double-balloon and Foley catheters in the second trimester medical termination of pregnancies will be compared.

Condition or Disease Intervention/Treatment Phase
  • Device: pregnancy termination
N/A

Detailed Description

Women will be randomised into two groups. Foley catheter was applied to one group and double balloon catheter to the other group. After catheter expulsion or if the catheters did not spontaneously expulsed after 24 hours, i.v. oxytocin infusion will be started. Abortions will be considered successful if there will be no need of another method for abortion.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Foley Catheter and Double-balloon Catheter in Second Trimester Pregnancy Termination
Actual Study Start Date :
Dec 1, 2016
Actual Primary Completion Date :
May 15, 2018
Actual Study Completion Date :
May 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Foley catheter

Foley catheter will be inserted through the cervical os and it will be filled with 40 ml saline. After insertion gentle traction will be applied for cervical ripening. Pregnancy termination will be achieved.

Device: pregnancy termination
Second trimester pregnancy termination for fetal anomali or in utero mord fetus will be done

Other: Double-balloon catheter

Double-balloon catheter will be inserted through the cervical os and both baloons will be filled with 40 ml saline. No traction will be applied. Pregnancy termination will be achieved.

Device: pregnancy termination
Second trimester pregnancy termination for fetal anomali or in utero mord fetus will be done

Outcome Measures

Primary Outcome Measures

  1. induction termination interval [during procedure]

    time from induction to pregnancy termination

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • pregnancy termination, gestational age from 14-24 weeks
Exclusion Criteria:
  • multiple gestation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kanuni SSTRH Istanbul Turkey

Sponsors and Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

Investigators

  • Principal Investigator: Berna Aslan Çein, KSSTRH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Berna Aslan Cetin, Md, ObGYN, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT03521674
Other Study ID Numbers:
  • 2016/8
First Posted:
May 11, 2018
Last Update Posted:
May 22, 2018
Last Verified:
May 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Berna Aslan Cetin, Md, ObGYN, Kanuni Sultan Suleyman Training and Research Hospital

Study Results

No Results Posted as of May 22, 2018